Holochem is seeking an Analytical Development Team Leader who will be responsible for building and leading a team in the development and evaluation of analytical methods, to support pharma development and manufacture of small batches.
Holochem was present at CPhI Worldwide, held in Frankfurt, Germany, from October 24th to 26th 2017.
We were located on the PolePharma pavilion on the ICSE International Contract Services Expo, hall 4.1, stand # 41D50.
CPhI newcomer Holochem, a brand-new CRO offering fine chemical R&D services for the development of key intermediates and exclusive APIs
The fine chemical industry counts a new player with a highly experienced R&D and executive management team. Holochem, CPhI newcomer founded by former Sanofi executive and Holis Technologies CEO Serge Calet, is a customer-oriented Contract Research Organization.
The company offers R&D services for the development of key intermediates and Active Pharmaceutical Ingredients, and produces pre-clinical batched for early-phase formulation and toxicological use.
Holochem, provider of Chemical and Process development services, and Holodiag, provider of Solid State solutions, announce the signing of a strategic partnership, enabling both companies to supply their customers with a full range of integrated fine chemical and API Contract Development & Manufacturing services, through all stages of the drug development lifecycle.
Holochem is seeking Chemistry lab technicians who generally work alongside chemists and other technicians. Typical job duties include organizing the lab workspace, maintaining cleanliness of equipment, creating chemical solutions, and performing chemical experiments.
Holochem is seeking a Process Chemistry Team Leader to develop our laboratory manufacturing to a 20L scale. The role involves responsibilities across various stages of Chemical Development, from route selection, risk assessment and custom manufacturing up to the kilo-scale.
EuroNanoMed presents the 10 projects that are selected for funding under the framework of the ENM II call. Among the selected projects is the NanoHeart project, coordinated by medical nanotechnology expert Patrick Couvreur of the Paris-Sud University, and co-developed by Holochem.
The NanoHeart project will develop nanoparticles loaded with adenosine to protect this molecule from rapid degradation.